SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-271921
Filing Date
2018-09-12
Accepted
2018-09-12 17:27:34
Documents
1
Period of Report
2018-09-12
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d586362d8k.htm 8-K 13989
  Complete submission text file 0001193125-18-271921.txt   15233
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 181067459
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10